ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension
Clinical trial NCT05056896 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05056896
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-03
- Primary completion
- 2024-11-27
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.